Hemas Holdings profit slides 3% in September quarter on cost pressures

Hemas Holdings, one of Sri Lanka's leading diversified conglomerates, saw its quarterly net profit decline by 3 percent to Rs2.0 billion for the three months ended September, reflecting headwinds across its operations.

The modest profit contraction was primarily driven by margin pressure across the company's business segments and mounting finance costs, which weighed on the bottom line during the quarter.

The results underscore the challenging operating environment facing Sri Lankan corporates as they navigate elevated interest rates and compressed profitability. Hemas, which operates across healthcare, consumer goods, and other sectors, has been managing cost pressures while attempting to maintain operational efficiency.

The company's performance in the quarter reflects broader economic headwinds affecting Sri Lanka's corporate sector, with many businesses facing similar margin compression and higher debt servicing costs amid the island nation's ongoing economic adjustments.